Search research articles
Contact Us
Filters
Showing results (91-100 of 192) with videos related to
Page
of 20
Sort By:
Neuroendocrinology
|
October 4, 2018
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Robert T Jensen, Lisa Bodei, Jaume Capdevila, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
November 26, 2015
Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer
Garcilaso Riesco-Eizaguirre, Juan Carlos Galofré, Enrique Grande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Paul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
International Journal of Cancer
|
June 15, 2019
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
Francesco Sclafani, Sanna Hulkki Wilson, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
Alice Dewdney, David Cunningham, Josep Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease
Francesco Sclafani, David Gonzalez de Castro, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C Yao, Marianne Pavel, Catherine Lombard-Bohas, et al.
The New England Journal of Medicine
|
July 12, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumors
Martyn E Caplin, Marianne Pavel, Jarosław B Ćwikła, et al.
Endocrine-Related Cancer
|
January 23, 2019
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials
James Yao, Abhishek Garg, David Chen, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
January 14, 2015
Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma
José Manuel Gómez Sáez, Paula Jiménez-Fonseca, Javier Santamaría Sandi, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 192) with videos related to
Sort By:
Page
of 20
Neuroendocrinology
|
October 4, 2018
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms
Robert T Jensen, Lisa Bodei, Jaume Capdevila, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
November 26, 2015
Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer
Garcilaso Riesco-Eizaguirre, Juan Carlos Galofré, Enrique Grande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Paul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
International Journal of Cancer
|
June 15, 2019
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
Francesco Sclafani, Sanna Hulkki Wilson, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C)
Alice Dewdney, David Cunningham, Josep Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
FcγRIIa and FcγRIIIa polymorphisms and cetuximab benefit in the microscopic disease
Francesco Sclafani, David Gonzalez de Castro, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C Yao, Marianne Pavel, Catherine Lombard-Bohas, et al.
The New England Journal of Medicine
|
July 12, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumors
Martyn E Caplin, Marianne Pavel, Jarosław B Ćwikła, et al.
Endocrine-Related Cancer
|
January 23, 2019
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials
James Yao, Abhishek Garg, David Chen, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
January 14, 2015
Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma
José Manuel Gómez Sáez, Paula Jiménez-Fonseca, Javier Santamaría Sandi, et al.
Page
of 20